Author argues UnitedHealth's ~20% drop is an overreaction to policy panic and sees it as a solid buy below $300 given cheap forward P/E and dividend.
UNH — LONG The author argues UNH's roughly 20% decline is an overreaction driven mainly by policy panic, which they expect to be short-lived given Trump's negotiating style. They cite a 15x-16x forward P/E for 2026 and a 2.5% dividend as evidence the valuation is de-risked below $300, and note UNH has been quick to adjust for price changes. The main stated risk is that the selloff continues 'to oblivion' rather than reversing.
Imo sub 300 is derisking the valuation and its a solid buy here.
This Reddit post, published January 27, 2026, features u/Solidplum101 discussing UNH. 1 trade idea extracted by AI with direction and confidence scoring.
Speakers: u/Solidplum101 · Tickers: UNH